| The effect of β-carotene on the mortality of male smokers is modified by smoking and by vitamins C and E: evidence against a uniform effect of nutrient 2020 · β-Carotene (BC) · Male smokers aged 50–69 years who smoked at least 5 cigarettes per day at entry | 20 mg | 2227 days | 14,564 |
| Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene 1998 · beta-carotene · Former blue asbestos workers at high risk of asbestos-related disease | 30 mg | 1826 days | 512 |
| Beta-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial 1999 · Continued beta-carotene therapy · Responders with oral leukoplakia after six months of beta-carotene treatment | 60 mg | 1 year | 11 |
| Double blind, cluster randomised trial of low dose supplementation with vitamin A or beta carotene on mortality related to pregnancy in Nepal. The NNIPS-2 Study Group 1999 · beta carotene · Married women of reproductive age in rural Nepal; some became pregnant during the study | 6 mg | 1278 days | — |
| The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers 1999 · beta-carotene (BC) · middle-aged male smokers | 20 mg | — | — |
| Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma 1999 · beta-carotene supplementation · U.S. male physicians aged 40–84 years; primary prevention of cancer | 25 mg | 438 days | — |
| Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers 2000 · beta-carotene · Men aged 50 to 69 who smoked cigarettes and had no history of stroke | 20 mg | 6 years | — |
| Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States) 2000 · beta-carotene · US male physicians; baseline age and health condition not specified | 25 mg | — | — |
| Vitamin E and beta carotene supplementation in high risk for stroke: a subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study 2000 · beta carotene · Men aged 50–69 who smoked and were included in the high-risk-for-stroke subgroup analysis; a reported subgroup had greater alcohol consumption | 20 mg | 6 years | — |
| A randomized trial of beta carotene and age-related cataract in US physicians 2003 · beta carotene · Male US physicians aged 40 to 84 years; healthy men | 25 mg | 438 days | — |
| The effect of folic acid on the development of stomach and other gastrointestinal cancers 2003 · Natural beta-carotene (N-betaC) · Patients with atrophic gastritis; age and sex not reported | 30 mg | 2 years | — |
| Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study 2004 · beta-carotene · men aged 50–69 who smoked | 20 mg | 8 years | — |
| Effects of alpha-tocopherol and beta-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial 2007 · beta-carotene only · Male smokers aged 50–69 years, free of cancer at baseline | 20 mg | 2227 days | — |
| A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study 2007 · Beta-carotene group · Women aged 40 years or older with a history of cardiovascular disease or at least three cardiovascular risk factors | 25 mg | 3431 days | — |
| Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake 2008 · Beta-carotene · Males aged 50–69 years who smoked at baseline and had no tuberculosis diagnosis before randomisation | 20 mg | 2228 days | — |
| Modification of the effect of vitamin E supplementation on the mortality of male smokers by age and dietary vitamin C 2009 · β-carotene · men aged 50–69 years who smoked at least 5 cigarettes per day | 20 mg | 8 years | — |
| Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival 2009 · β-carotene · Caucasian male smokers aged 50–69 years; prostate cancer cases were analysed in this report | 20 mg | 8 years | — |
| No dose-dependent increase in fracture risk after long-term exposure to high doses of retinol or beta-carotene 2013 · 30 mg/day beta-carotene group · Adults previously exposed to blue asbestos; 664 females and 1,658 males across the study | 30 mg | 2192 days | — |
| No dose-dependent increase in fracture risk after long-term exposure to high doses of retinol or beta-carotene 2013 · 0.75 mg/day beta-carotene group · Adults previously exposed to blue asbestos; 664 females and 1,658 males across the study | 750 mcg | 2192 days | — |
| Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis 2013 · β-carotene alone · Finnish male smokers aged 50–69 | 20 mg | 2227 days | — |
| Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study 2014 · β-carotene · Finnish male smokers aged 50–69 at baseline without self-reported cirrhosis | 20 mg | 2922 days | — |
| Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas 1995 · Beta-carotene intervention · Adults with at least one histologically confirmed colorectal adenoma that had been removed | 20 mg | 1461 days | — |
| Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study 1995 · beta-carotene · Male cigarette smokers aged 50–69 years | 20 mg | 8 years | — |
| Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial 1996 · beta carotene group · Men aged 50–69 who smoked and were free of known coronary heart disease at baseline | 20 mg | 1716 days | — |
| Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation 1996 · beta carotene supplementation · Men and women with mean age 63.2 years enrolled in a trial to prevent nonmelanoma skin cancer | 50 mg | 1570 days | — |
| Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance 1996 · beta-carotene · Men aged 50–69 years who smoked at least five cigarettes daily | 20 mg | 2227 days | — |
| Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial 1998 · beta-carotene · Male smokers aged 50–69 years | 20 mg | 2228 days | — |
| Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group 1999 · vitamin A · pregnant HIV-infected women in their third trimester | 30 mg | — | 368 |
| MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience 1999 · antioxidant vitamin supplement · Men and women aged 40–80 at elevated risk of coronary heart disease death due to prior coronary heart disease, occlusive non-coronary arterial disease, diabetes mellitus, or treated hypertension | 20 mg | 5 years | — |
| The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers 1999 · both AT and BC · middle-aged male smokers | 20 mg | — | — |
| Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers 2000 · alpha-tocopherol and beta-carotene · Men aged 50 to 69 who smoked cigarettes and had no history of stroke | 20 mg | 6 years | — |
| Vitamin E and beta carotene supplementation in high risk for stroke: a subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study 2000 · alpha tocopherol and beta carotene · Men aged 50–69 who smoked and were included in the high-risk-for-stroke subgroup analysis | 20 mg | 6 years | — |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Antioxidants · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 15 mg | 8 years | — |
| Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 2004 · antioxidants alone · Adults aged 55–81 years with age-related macular degeneration categories 1–4 or other AREDS ocular eligibility; participants in AMD categories 2–4 were eligible for this arm, and category 1 participants could also receive antioxidants | 15 mg | 339 weeks | — |
| Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study 2004 · alpha-tocopherol plus beta-carotene · men aged 50–69 who smoked | 20 mg | 8 years | — |
| The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements 2004 · active intervention group · Participants at high risk for lung cancer because of a history of smoking or asbestos exposure | 30 mg | — | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Vitamin A without multivitamin · HIV-positive pregnant Tanzanian women | 30 mg | — | — |
| Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients 2006 · supplement arm · Head and neck cancer patients treated by radiation therapy | 30 mg | — | — |
| Effects of alpha-tocopherol and beta-carotene supplementation on upper aerodigestive tract cancers in a large, randomized controlled trial 2007 · alpha-tocopherol plus beta-carotene · Male smokers aged 50–69 years, free of cancer at baseline | 20 mg | 2227 days | — |
| Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients 2008 · supplementation · Head and neck cancer patients treated with radiation therapy; age and sex not stated | 30 mg | — | — |
| Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake 2008 · Vitamin E and beta-carotene · Males aged 50–69 years who smoked at baseline and had no tuberculosis diagnosis before randomisation | 20 mg | 2228 days | — |
| Modification of the effect of vitamin E supplementation on the mortality of male smokers by age and dietary vitamin C 2009 · vitamin E + β-carotene · men aged 50–69 years who smoked at least 5 cigarettes per day | 20 mg | 8 years | — |
| Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial 2009 · Factor D · Adults in Linxian, China; age and sex details not given | 15 mg | 313 weeks | — |
| Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival 2009 · α-tocopherol and β-carotene · Caucasian male smokers aged 50–69 years; prostate cancer cases were analysed in this report | 20 mg | 8 years | — |
| Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial 2009 · CARET intervention arm · Men aged 45–69 or 50–69 who were current or former heavy smokers or asbestos-exposed workers; the report analyzes male participants only | 30 mg | — | — |
| Sex differences in the effects of maternal vitamin supplements on mortality and morbidity among children born to HIV-infected women in Tanzania 2010 · Vitamin A plus β-carotene · HIV-infected pregnant women enrolled at 12–27 weeks’ gestation in Dar es Salaam, Tanzania; treatment continued after delivery while breastfeeding was nearly universal | 30 mg | — | — |
| Vitamin E serum levels and controlled supplementation and risk of amyotrophic lateral sclerosis 2013 · combined β-carotene/α-tocopherol · Finnish male smokers aged 50–69 | 20 mg | 2227 days | — |
| Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 2013 · Antioxidants · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4) | 15 mg | 339 weeks | — |
| Plasma retinol and total carotenes and fracture risk after long-term supplementation with high doses of retinol 2014 · beta-carotene group · Adults aged 1990–1996 enrollment, 663 men and 335 women combined, in a cancer prevention program | 30 mg | 2847 days | — |
| No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 2014 · antioxidants · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years | 15 mg | 9 years | — |
| Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study 2014 · α-tocopherol and β-carotene · Finnish male smokers aged 50–69 at baseline without self-reported cirrhosis | 20 mg | 2922 days | — |
| Vitamin E administration may decrease the incidence of pneumonia in elderly males 2016 · AT + BC (vitamin E + β-carotene) · Finnish males aged 50–69 at entry who smoked at least 5 cigarettes per day and started smoking at age 21 or older; the analysis subgroup included men who smoked 5–19 cigarettes per day and exercised at leisure at baseline | 20 mg | 8 years | — |
| No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18 2019 · Original AREDS formula without modification · Adults with bilateral large drusen or late AMD in one eye and large drusen in the fellow eye | 15 mg | 5 years | — |
| The effect of β-carotene on the mortality of male smokers is modified by smoking and by vitamins C and E: evidence against a uniform effect of nutrient 2020 · α-Tocopherol and β-carotene (AT + BC) · Male smokers aged 50–69 years who smoked at least 5 cigarettes per day at entry | 20 mg | 2227 days | — |
| Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study 1995 · beta-carotene and alpha-tocopherol · Male cigarette smokers aged 50–69 years | 20 mg | 8 years | — |
| Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer 1993 · retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis | 40 mg | 87 weeks | — |
| Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial 1996 · alpha tocopherol plus beta carotene group · Men aged 50–69 who smoked and were free of known coronary heart disease at baseline | 20 mg | 1716 days | — |
| Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease 1996 · active-treatment group · Smokers, former smokers, and workers exposed to asbestos; age and sex not specified | 30 mg | 4 years | — |
| Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial 1996 · active intervention group · Men and women at high risk of developing lung cancer | 30 mg | — | — |
| Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance 1996 · alpha-tocopherol and beta-carotene · Men aged 50–69 years who smoked at least five cigarettes daily | 20 mg | 2227 days | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C was common at baseline | 6 mg | 2 years | — |
| Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial 1998 · alpha-tocopherol plus beta-carotene · Male smokers aged 50–69 years | 20 mg | 2228 days | — |
| Beta-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial 1999 · Initial beta-carotene treatment · Adults with oral leukoplakia | 60 mg | 26 weeks | 54 |
| Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment 1997 · beta carotene · Fishermen and women with oral leukoplakia in Kerala, India | 51.4 mg | 1 year | 46 |
| Prevention of exercise-induced asthma by a natural isomer mixture of beta-carotene 1999 · beta-carotene · Patients with exercise-induced asthma; age and sex not reported | 64 mg | 7 days | 38 |
| Treatment with 9-cis β-carotene-rich powder in patients with retinitis pigmentosa: a randomized crossover trial 2013 · 9-cis β-carotene · Adults aged 18 years or older with retinitis pigmentosa | 20 mg | 90 days | 29 |
| Response of oral leukoplakia to beta-carotene 1990 · beta-carotene · Patients with oral leukoplakia; age and sex not reported. | 30 mg | 26 weeks | 24 |
| Effect of beta-carotene on immunological indexes in healthy male smokers 1993 · beta-carotene group (lymphocyte proliferation) · Healthy male cigarette smokers | 20 mg | 14 weeks | 24 |
| Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema 2003 · beta-carotene · Volunteers with skin type II | 24 mg | 12 weeks | 12 |
| The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial 1999 · beta-carotene only · Male smokers aged 50–69 with intermittent claudication | 20 mg | 193 weeks | — |
| Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans 2000 · Carotenoid supplement · Healthy volunteers | 25 mg | 12 weeks | — |
| Physical activity and the common cold in men administered vitamin E and beta-carotene 2003 · Beta-carotene only · Men aged 50–69 who smoked; common-cold risk was assessed in physically active subgroups | 20 mg | 2227 days | — |
| A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II 2007 · beta carotene group among newly recruited participants · Men older than 65 years; no specific condition stated | 25 mg | 1 year | — |
| A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II 2007 · beta carotene group among continuing participants · Men older than 65 years continuing from the Physicians' Health Study; no specific condition stated | 25 mg | 657 days | — |
| Vitamin E, vitamin C, beta carotene, and cognitive function among women with or at risk of cardiovascular disease: The Women's Antioxidant and Cardiovascular Study 2009 · β-carotene group · Women aged 65 years or older in the cognitive substudy, with cardiovascular disease or at least three coronary risk factors | 25 mg | 3249 days | — |
| Differential effects of low-dose and high-dose beta-carotene supplementation on the signs of photoaging and type I procollagen gene expression in human skin in vivo 2010 · low-dose group · Healthy women over age 50 | 30 mg | 90 days | — |
| Differential effects of low-dose and high-dose beta-carotene supplementation on the signs of photoaging and type I procollagen gene expression in human skin in vivo 2010 · high-dose group · Healthy women over age 50 | 90 mg | 90 days | — |
| Short term effects of palm-tocotrienol and palm-carotenes on vascular function and cardiovascular disease risk: A randomised controlled trial 2016 · CC-60 · Men and women aged 18–70 years with type 2 diabetes, impaired fasting glucose and/or elevated waist circumference, at increased risk of impaired vascular function | 21 mg | 8 weeks | — |
| The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers 1993 · beta-carotene · Men and women aged 50–69 who were current smokers or had quit within the past 6 years and had a smoking history of at least 20 pack-years | 30 mg | 548 days | — |
| Vitamin A or beta-carotene supplementation reduces but does not eliminate maternal night blindness in Nepal 1998 · Beta-carotene · Pregnant women in rural Nepal; age range and specific condition not reported | 1 mg | — | — |
| "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants 1999 · antioxidant vitamins and minerals supplementation · Women aged 35 to 60 years and men aged 45 to 60 years, without a stated condition | 6 mg | 8 years | — |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye | 15 mg | 8 years | — |
| Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13 2004 · antioxidants plus zinc · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility | 15 mg | 339 weeks | — |
| The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals 2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population | 6 mg | 2739 days | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women | 30 mg | — | — |
| Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels? 2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 6 mg | 2739 days | — |
| [The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of antioxidant vitamins and minerals on health] 2006 · antioxidant supplementation · Middle-aged adults in the general population | 6 mg | 2738 days | — |
| Antioxidant supplementation increases the risk of skin cancers in women but not in men 2007 · antioxidant group · French adult women and men in a general-population primary-prevention trial | 6 mg | 2738 days | — |
| Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study 2010 · antioxidant supplementation · French women aged 35–60 years and men aged 45–60 years | 6 mg | 2738 days | — |
| Sex differences in the effects of maternal vitamin supplements on mortality and morbidity among children born to HIV-infected women in Tanzania 2010 · Multivitamins plus vitamin A and β-carotene · HIV-infected pregnant women enrolled at 12–27 weeks’ gestation in Dar es Salaam, Tanzania; treatment continued after delivery while breastfeeding was nearly universal | 30 mg | — | — |
| Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35 2013 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4) | 15 mg | 339 weeks | — |
| No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38 2014 · antioxidants plus zinc · Adults with intermediate age-related macular degeneration in one or both eyes or late age-related macular degeneration in one eye; mean age 69 years | 15 mg | 9 years | — |
| Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer 1993 · riboflavin plus retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis | 40 mg | 87 weeks | — |
| Effect of micronutrient supplementation on infection in institutionalized elderly subjects: a controlled trial 1997 · combination of trace elements and vitamins · Institutionalized elderly subjects in a geriatric center; low serum vitamin C, zinc and selenium were common at baseline | 6 mg | 2 years | — |
| Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants 1998 · active medication · Adults with colorectal polyps; age range and sex not stated | 15 mg | 3 years | — |
| Efficacy of Natural β-Carotene Chewable Tablets Derived from Banana (Musa AA) Pulp in Reducing UV-Induced Skin Erythema 2024 · tested chewable tablet (TCT) group · Healthy Thai males aged 35–50 years | 8 mg | 16 weeks | 20 |
| Supplementation with beta-carotene or a similar amount of mixed carotenoids protects humans from UV-induced erythema 2003 · carotenoid mix · Volunteers with skin type II | 8 mg | 12 weeks | 12 |
| Acute effects of ozone on pulmonary function of cyclists receiving antioxidant supplements 1998 · supplementation group · Amateur cyclists; age and sex not reported; no condition stated | 15 mg | 90 days | 12 |
| The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial 1999 · alpha-tocopherol plus beta-carotene · Male smokers aged 50–69 with intermittent claudication | 20 mg | 193 weeks | — |
| Carotenoids and carotenoids plus vitamin E protect against ultraviolet light-induced erythema in humans 2000 · Carotenoid supplement plus vitamin E · Healthy volunteers | 25 mg | 12 weeks | — |
| Effects of vitamin A supplementation during pregnancy and early lactation on body weight of South African HIV-infected women 2001 · Pregnancy supplementation · HIV-seropositive pregnant women aged not stated, enrolled at 28–32 weeks gestation | 30 mg | — | — |
| The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract 2002 · vitamin group · Adult American and English outpatients with early age-related cataract | 18 mg | 3 years | — |
| Physical activity and the common cold in men administered vitamin E and beta-carotene 2003 · Vitamin E and beta-carotene · Men aged 50–69 who smoked; common-cold risk was assessed in physically active subgroups | 20 mg | 2227 days | — |
| Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients 2005 · supplement arm · Head and neck cancer patients receiving radiation therapy; age and sex not stated | 30 mg | 3 years | — |
| The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers 1993 · retinol plus beta-carotene · Men and women aged 50–69 who were current smokers or had quit within the past 6 years and had a smoking history of at least 20 pack-years | 30 mg | 548 days | — |
| Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone 1998 · supplement group · Mexico City street workers exposed to high ozone levels; age and sex not stated | 15 mg | 26 weeks | — |
| 9-cis beta-carotene-rich powder of the alga Dunaliella bardawil increases plasma HDL-cholesterol in fibrate-treated patients 2006 · Dunaliella capsules, first trial · Fibrate-treated men with plasma HDL-cholesterol below 40 mg/dl | 60 mg | 6 weeks | 20 |
| [Study of the antioxidant drug "Karinat" in patients with chronic atrophic gastritis] 2004 · Karinat · Patients with chronic multifocal atrophic gastritis | 5 mg | 26 weeks | 34 |
| [Study of an antioxidant dietary supplement "Karinat" in patients with benign breast disease] 2004 · Karinat · Patients with benign breast disease, including mastopathy | 5 mg | 26 weeks | 33 |
| Increased vitamin plasma levels in Swedish military personnel treated with nutrients prior to automatic weapon training 2011 · Nutrients (active treatment) · Normally hearing Swedish military personnel, officers and military academy trainees, ages 18 and older, undergoing weapons training | 18 mg | 2 days | 31 |
| Adjunctive daily supplementation with encapsulated fruit, vegetable and berry juice powder concentrates and clinical periodontal outcomes: a double-blind RCT 2012 · Test 1 – Six capsules daily containing the total equivalent of four FV capsules, and two placebo capsules · Men and women aged 30–60 with chronic periodontitis; medically healthy and non-smokers | 7.5 mg | 274 days | 20 |
| Adjunctive daily supplementation with encapsulated fruit, vegetable and berry juice powder concentrates and clinical periodontal outcomes: a double-blind RCT 2012 · Test 2 – Six FVB capsules daily · Men and women aged 30–60 with chronic periodontitis; medically healthy and non-smokers | 7.5 mg | 274 days | 20 |
| The effects of antioxidant vitamin supplementation on expiratory flow rates at rest and during exercise 2015 · antioxidant vitamin supplementation (AVS) · healthy nonsmoking adults, 5 men and 5 women, consuming fewer than 5 servings of fruit and vegetables per day | 15,000 IU | 4 weeks | 10 |
| Changes in ventilatory threshold at high altitude: effect of antioxidants 2006 · antioxidant (AO) supplement group · Physically fit males aged 25 ± 5 years exposed to high altitude at 4300 m | 12 mg | 5 weeks | — |
| French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial 2011 · antioxidant supplementation · French adults aged 45–60 years enrolled in the SU.VI.MAX study | 6 mg | 2922 days | — |
| Combination oral antioxidant supplementation reduces blood pressure 1997 · antioxidants · Hypertensive and normotensive adult outpatients; 21 were attending for hypertension treatment and 17 were normotensive outpatients with minor gastrointestinal complaints. | 30 mg | 8 weeks | — |
| Determinants of increase in plasma concentration of beta-carotene after chronic oral supplementation. The Skin Cancer Prevention Study Group 1991 · subjects receiving oral supplementation · Adults; sex and health conditions not specified | 50 mg | 1 year | 582 |
| Effect of supplemental beta-carotene on plasma concentrations of carotenoids, retinol, and alpha-tocopherol in humans 1998 · supplemental beta-carotene · men and women with early-stage cancer of the oral cavity, pharynx, or larynx who had been cured | 50 mg | 5 years | 259 |
| Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study 1997 · receiving supplemental beta-carotene · Men aged 58–76 years from the metropolitan Helsinki study center | 20 mg | 2446 days | 237 |
| Maternal vitamin A or beta-carotene supplementation in lactating bangladeshi women benefits mothers and infants but does not prevent subclinical deficiency 1999 · beta-carotene · Lactating women in Bangladesh, 1–3 weeks postpartum | 7.8 mg | 270 days | 73 |
| Low-dose beta-carotene supplementation and deworming improve serum vitamin A and beta-carotene concentrations in preschool children of Bangladesh 2010 · Group III (β-carotene + placebo) · Preschool children aged 24–60 months, both sexes, infected with Ascaris lumbricoides | 1.2 mg | 26 weeks | 58 |
| Effects of 4 y of oral supplementation with beta-carotene on serum concentrations of retinol, tocopherol, and five carotenoids 1997 · 25 mg beta-carotene/d · People enrolled in a clinical trial intended to prevent colonic adenomas; age and sex not specified | 25 mg | 1461 days | 54 |
| Low-dose beta-carotene supplementation and deworming improve serum vitamin A and beta-carotene concentrations in preschool children of Bangladesh 2010 · Group I (albendazole + β-carotene) · Preschool children aged 24–60 months, both sexes, infected with Ascaris lumbricoides | 1.2 mg | 26 weeks | 52 |
| Increase in serum beta-carotene following dark green leafy vegetable supplementation in Mebendazole-treated school children in Bangladesh 2001 · DGLV group · Children aged 8–12 years in Bangladesh treated for Ascaris lumbricoides | 4.4 mg | 6 weeks | 37 |
| Increase in serum beta-carotene following dark green leafy vegetable supplementation in Mebendazole-treated school children in Bangladesh 2001 · Sweet pumpkin group · Children aged 8–12 years in Bangladesh treated for Ascaris lumbricoides | 1.5 mg | 6 weeks | 36 |
| The effect of beta-carotene supplementation on the immune function of blood monocytes from healthy male nonsmokers 1997 · beta-carotene · healthy adult male nonsmokers | 15 mg | 26 days | 25 |
| Effects of three-month oral supplementation of beta-carotene and vitamin C on serum concentrations of carotenoids and vitamins in middle-aged subjects: a pilot study for a randomized controlled trial to prevent gastric cancer in high-risk Japanese population 2000 · Low-dose beta-carotene group · Adults aged 40–69 with chronic atrophic gastritis | 3 mg | 90 days | 19 |
| Effects of three-month oral supplementation of beta-carotene and vitamin C on serum concentrations of carotenoids and vitamins in middle-aged subjects: a pilot study for a randomized controlled trial to prevent gastric cancer in high-risk Japanese population 2000 · High-dose beta-carotene group · Adults aged 40–69 with chronic atrophic gastritis | 30 mg | 90 days | 18 |
| Low β-carotene bioaccessibility and bioavailability from high fat, dairy-based meal 2024 · β-carotene with placebo · Healthy men aged 18–45 years | 15 mg | 1 day | 12 |
| Gastric acidity influences the blood response to a beta-carotene dose in humans 1996 · beta-carotene dose under crossover gastric-pH conditions · 12 normal adults, 23–68 years, 5 women and 7 men | 120 mg | 1 day | 12 |
| Beta-carotene's effects on serum lipoproteins and immunologic indices in humans 1991 · 15 mg/day beta-carotene group · Healthy humans; age and sex not specified | 15 mg | 30 days | 10 |
| Beta-carotene's effects on serum lipoproteins and immunologic indices in humans 1991 · 45 mg/day beta-carotene group · Healthy humans; age and sex not specified | 45 mg | 30 days | 10 |
| Beta-carotene's effects on serum lipoproteins and immunologic indices in humans 1991 · 180 mg/day beta-carotene group · Healthy humans; age and sex not specified | 180 mg | 30 days | 10 |
| Beta-carotene's effects on serum lipoproteins and immunologic indices in humans 1991 · 300 mg/day beta-carotene group · Healthy humans; age and sex not specified | 300 mg | 30 days | 10 |
| Biofortified cassava increases β-carotene and vitamin A concentrations in the TAG-rich plasma layer of American women 2013 · Biofortified cassava porridge with added oil · Healthy, well-nourished American adult women | 2 mg | 1 day | 10 |
| Biofortified cassava increases β-carotene and vitamin A concentrations in the TAG-rich plasma layer of American women 2013 · Biofortified cassava porridge without added oil · Healthy, well-nourished American adult women | 2 mg | 1 day | 10 |
| Ingestion by men of a combined dose of beta-carotene and lycopene does not affect the absorption of beta-carotene but improves that of lycopene 1997 · all-trans beta-carotene dose · 10 healthy men | 60 mg | 4 weeks | 10 |
| Beta-carotene conversion to vitamin A decreases as the dietary dose increases in humans 2010 · 20-mg dose · Seven adult volunteers: 4 men and 3 women; no condition stated | 20 mg | 1 day | 7 |
| Beta-carotene conversion to vitamin A decreases as the dietary dose increases in humans 2010 · 40-mg dose · Seven adult volunteers: 4 men and 3 women; no condition stated | 40 mg | 1 day | 7 |
| Plasma and buccal mucosal cell response to short-term supplementation with all trans-beta-carotene and lycopene in human volunteers 2003 · 15 mg beta-carotene group · Human volunteers with no stated condition | 15 mg | 7 days | 6 |
| Plasma and buccal mucosal cell response to short-term supplementation with all trans-beta-carotene and lycopene in human volunteers 2003 · 30 mg beta-carotene group · Human volunteers with no stated condition | 30 mg | 7 days | 6 |
| Plasma concentration response to drinks containing beta-carotene as carrot juice or formulated as a water dispersible powder 2002 · Carrot juice-based drink, 6 mg/d beta-carotene · Volunteers; age, sex, and health status not reported | 6 mg | 6 weeks | 4 |
| Plasma concentration response to drinks containing beta-carotene as carrot juice or formulated as a water dispersible powder 2002 · Carrot juice-based drink, 18 mg/d beta-carotene · Volunteers; age, sex, and health status not reported | 18 mg | 6 weeks | 4 |
| Plasma concentration response to drinks containing beta-carotene as carrot juice or formulated as a water dispersible powder 2002 · Water-dispersible beta-carotene powder drink, 7.2 mg/d · Volunteers; age, sex, and health status not reported | 7.2 mg | 6 weeks | 4 |
| Plasma concentration response to drinks containing beta-carotene as carrot juice or formulated as a water dispersible powder 2002 · Water-dispersible beta-carotene powder drink, 21.6 mg/d · Volunteers; age, sex, and health status not reported | 21.6 mg | 6 weeks | 4 |
| Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis 2001 · high dose supplementation · Patients with cystic fibrosis; age and sex not specified | 1 mg/kg | 90 days | — |
| Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis 2001 · low dose supplementation · Patients with cystic fibrosis; age and sex not specified | 10 mg | 90 days | — |
| Supplementing lactating women with puréed papaya and grated carrots improved vitamin A status in a placebo-controlled trial 2001 · beta-carotene group · Lactating women with infants aged 2–12 months in Zimbabwe | 6 mg | 60 days | — |
| Circulating levels of retinol, tocopherol and carotenoid in Nepali pregnant and postpartum women following long-term beta-carotene and vitamin A supplementation 2001 · beta-carotene · Pregnant and postpartum Nepali women | 6 mg | — | — |
| A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses 2002 · alpha- and beta-carotene (carotene-rich palm oil) · Healthy men and women aged 25–45 years from five European regions | 15 mg | — | — |
| Accumulation and interactions of beta-carotene and alpha-tocopherol in patients with adenomatous polyps 2002 · natural BC · Volunteers with colonic adenomatous polyps; age and sex not reported | 25,000 IU | 43 days | — |
| Carotenoid composition of human milk during the first month postpartum and the response to beta-carotene supplementation 2002 · beta-carotene · Healthy, well-nourished women aged 19–39 years who were breastfeeding, days 4–32 postpartum | 30 mg | 4 weeks | — |
| Redistribution of vitamin A after iron supplementation in Indonesian infants 2003 · 2.4 mg beta-carotene · Indonesian infants aged 4 months | 2.4 mg | 26 weeks | — |
| Red palm oil supplementation: a feasible diet-based approach to improve the vitamin A status of pregnant women and their infants 2003 · experimental group (red palm oil) · Pregnant women recruited at 16 to 24 weeks of gestation | 2.4 mg | 8 weeks | — |
| Serum beta-carotene before and after beta-carotene supplementation 1992 · beta-carotene group · Men aged 30–69 years; no condition stated | 20 mg | 60 days | — |
| Reduction in plasma or skin alpha-tocopherol concentration with long-term oral administration of beta-carotene in humans and mice 1992 · 15 mg beta-carotene group · Normal human subjects; age and sex not reported | 15 mg | 270 days | — |
| Reduction in plasma or skin alpha-tocopherol concentration with long-term oral administration of beta-carotene in humans and mice 1992 · 30 mg beta-carotene group · Normal human subjects; age and sex not reported | 30 mg | 270 days | — |
| Reduction in plasma or skin alpha-tocopherol concentration with long-term oral administration of beta-carotene in humans and mice 1992 · 45 mg beta-carotene group · Normal human subjects; age and sex not reported | 45 mg | 270 days | — |
| Reduction in plasma or skin alpha-tocopherol concentration with long-term oral administration of beta-carotene in humans and mice 1992 · 60 mg beta-carotene group · Normal human subjects; age and sex not reported | 60 mg | 270 days | — |
| Biofortified yellow cassava and vitamin A status of Kenyan children: a randomized controlled trial 2016 · β-carotene supplement group · Children aged 5–13 years with marginal vitamin A status | 1.05 mg | 130 days | — |
| Skin lycopene is destroyed preferentially over beta-carotene during ultraviolet irradiation in humans 1995 · beta-carotene group · healthy women | 120 mg | 1 day | — |
| Changes in serum carotenoids in subjects with colorectal adenomas after 24 mo of beta-carotene supplementation. Australian Polyp Prevention Project Investigators 1994 · beta-carotene · Adults with colorectal adenomas; 139 men and 85 women were enrolled, but arm-specific age and sex counts are not reported. | 20 mg | 2 years | — |
| Carotenoid and tocopherol concentrations in plasma, peripheral blood mononuclear cells, and red blood cells after long-term beta-carotene supplementation in men 1996 · 50 mg beta-carotene alone · Adult male physicians from the Boston area; no diagnosed condition stated | 25 mg | 438 days | — |
| Carotenoid and tocopherol concentrations in plasma, peripheral blood mononuclear cells, and red blood cells after long-term beta-carotene supplementation in men 1996 · both (aspirin and beta-carotene) · Adult male physicians from the Boston area; no diagnosed condition stated | 25 mg | 438 days | — |
| Beta-carotene-induced enhancement of natural killer cell activity in elderly men: an investigation of the role of cytokines 1998 · beta-carotene group · Men aged 65–88 years (mean age 73) | 25 mg | 438 days | — |
| Beta-carotene concentration in buccal mucosal cells with and without dysplastic oral leukoplakia after long-term beta-carotene supplementation in male smokers 1998 · beta-carotene · Male smokers in the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study; age and health conditions not specified | 20 mg | — | — |
| Decreased excretion of thioethers in urine of smokers after the use of beta-carotene 1992 · beta-carotene group · Smokers; age and sex not reported | 20 mg | 14 weeks | 62 |
| The influence of beta-carotene on homocysteine level and oxidative stress in lead-exposed workers 2014 · beta-carotene group · Healthy male workers chronically exposed to lead | 10 mg | 12 weeks | 33 |
| No effect of beta-carotene supplementation on plasma lipoproteins in healthy smokers 1994 · beta-carotene group · healthy male cigarette smokers | 20 mg | 14 weeks | 25 |
| Effect of beta-carotene on immunological indexes in healthy male smokers 1993 · beta-carotene group (lymphocyte subsets) · Healthy male cigarette smokers | 20 mg | 14 weeks | 21 |
| Beta-carotene in HIV infection 1993 · beta-carotene · HIV-seropositive patients | 180 mg | 4 weeks | 21 |
| Dietary supplementation of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitus 2000 · beta-carotene supplementation · Adults with long-standing non-insulin-dependent diabetes mellitus; age range and sex not specified | 60 mg | 3 weeks | 20 |
| Effect of the antioxidants selenium and beta-carotene on HIV-related endothelium dysfunction 1998 · beta-carotene · HIV-seropositive subjects | 60 mg | 1 year | 11 |
| Effects of beta-carotene repletion on beta-carotene absorption, lipid peroxidation, and neutrophil superoxide formation in young men 1990 · 120 mg daily group · Young men aged 18–30 years on a carotenoid-free liquid diet | 120 mg | 4 weeks | 8 |
| Effect of a single bout of exercise and beta-carotene supplementation on the urinary excretion of 8-hydroxy-deoxyguanosine in humans 1997 · beta-carotene supplement group · Healthy nonsmoking men, 19–22 years old, untrained | 30 mg | 30 days | 8 |
| Effects of beta-carotene repletion on beta-carotene absorption, lipid peroxidation, and neutrophil superoxide formation in young men 1990 · 15 mg daily group · Young men aged 18–30 years on a carotenoid-free liquid diet | 15 mg | 4 weeks | 7 |
| Beta-carotene supplementation increases antioxidant capacity of plasma in older women 1994 · beta-carotene · Healthy women aged 62–80 years | 90 mg | 3 weeks | 6 |
| The effect of a low carotenoid diet on malondialdehyde-thiobarbituric acid (MDA-TBA) concentrations in women: a placebo-controlled double-blind study 1998 · Group C (control group) · Pre-menopausal women | 500 mcg | 100 days | 5 |
| The effect of a low carotenoid diet on malondialdehyde-thiobarbituric acid (MDA-TBA) concentrations in women: a placebo-controlled double-blind study 1998 · Group P (placebo group), days 60 to 100 · Pre-menopausal women | 500 mcg | 40 days | 4 |
| Lipoprotein carotenoid profiles and the susceptibility of low density lipoprotein to oxidative modification in healthy elderly volunteers 2000 · Carotene group · Healthy adults aged 65 years or older | 11.9 mg | 12 weeks | — |
| Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women 2006 · beta-carotene · Healthy, nonsmoking postmenopausal women aged 50–70 years | 12 mg | 8 weeks | — |
| Investigation of the effects of oral administration of vitamin E and beta-carotene on the chemiluminescence responses and the frequency of sister chromatid exchanges in circulating leukocytes from cigarette smokers 1990 · Group 2 · Asymptomatic cigarette smokers; age and sex not specified | 40 mg | 6 weeks | — |
| Limited appearance of apocarotenoids is observed in plasma after consumption of tomato juices: a randomized human clinical trial 2018 · High-β-carotene tomato juice · Healthy subjects; age and sex not specified | 30.4 mg | 4 weeks | — |
| Effect of beta-carotene supplementation on indices of colonic cell proliferation 1995 · beta-carotene · Adults with a history of colonic polyps or prior colon cancer; mean ages 59.6 and 67.2 years, respectively; men and women | 30 mg | 90 days | — |
| Lack of effects of beta-carotene on lipids and sex steroid hormones in hyperlipidemics 1994 · beta-carotene, hyperlipidemic patients · Adults with Type IIa or IIb hyperlipidemia; age range and sex not stated | 300 mg | 30 days | — |
| Lack of effects of beta-carotene on lipids and sex steroid hormones in hyperlipidemics 1994 · beta-carotene, healthy subjects · Healthy adults; age range and sex not stated | 300 mg | 30 days | — |
| Effects of beta-carotene supplementation on lipid peroxidation in humans 1994 · beta-carotene group, smokers · Smokers; age and sex not reported | 20 mg | 4 weeks | — |
| Effects of beta-carotene supplementation on lipid peroxidation in humans 1994 · beta-carotene group, nonsmokers · Nonsmokers; age and sex not reported | 20 mg | 4 weeks | — |
| Natural killer cell activity in elderly men is enhanced by beta-carotene supplementation 1996 · beta-carotene-supplemented group · Men aged 51–86 years; 38 were middle-aged (51–64) and 21 were elderly (65–86) | 25 mg | — | — |
| The influence of antioxidant nutrients on platelet function in healthy volunteers 1997 · beta-carotene · Healthy volunteers aged 20–50 years | 15 mg | 8 weeks | — |
| Enhanced plasma level of lipid peroxidation in Iranians could be improved by antioxidants supplementation 1997 · beta-carotene and placebo for alpha-tocopherol · Male medical students; age not reported; no condition reported | 30 mg | 10 weeks | — |
| Immunomodulatory effect of beta-carotene on T lymphocyte subsets in patients with resected colonic polyps and cancer 1997 · beta-carotene · Patients with previous adenomatous colonic polyps or colon cancer | 30 mg | 90 days | — |
| Bioefficacy of beta-carotene dissolved in oil studied in children in Indonesia 2001 · beta-carotene and retinyl palmitate capsules · Indonesian children aged 8–11 years | 160 mcg | 10 weeks | 35 |
| Supplementation with antioxidants prior to bone marrow transplantation 1997 · BMT(+) · Bone marrow transplant patients receiving conditioning therapy | 45 mg | 3 weeks | 16 |
| Carotenoid absorption in humans consuming tomato sauces obtained from tangerine or high-beta-carotene varieties of tomatoes 2007 · High-beta-carotene sauce group · Healthy adults, 6 male and 6 female; age not reported | 17 mg | 1 day | 12 |
| Low β-carotene bioaccessibility and bioavailability from high fat, dairy-based meal 2024 · β-carotene with iron · Healthy men aged 18–45 years | 15 mg | 1 day | 12 |
| Low β-carotene bioaccessibility and bioavailability from high fat, dairy-based meal 2024 · β-carotene with zinc · Healthy men aged 18–45 years | 15 mg | 1 day | 12 |
| Effect of supplementation with beta-carotene and vitamin A on lung nutrient levels 1998 · active arm · 21 men recruited to a lung nutrient biomarker study within CARET; age and underlying risk condition not specified | 30 mg | 26 weeks | 10 |
| GLV supplements increased plasma beta-carotene, vitamin C, zinc and hemoglobin in young healthy adults 2006 · standard meal with tablets · Young healthy adults; sex and age range not reported | 10 mg | 1 day | 4 |
| Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function 2000 · CF supplementation group · Patients with cystic fibrosis, aged 12.8 ± 6.3 years | 1 mg/kg | 24 weeks | — |
| Accumulation and interactions of beta-carotene and alpha-tocopherol in patients with adenomatous polyps 2002 · combination BC/VE · Volunteers with colonic adenomatous polyps; age and sex not reported | 25,000 IU | 43 days | — |
| Zinc plus beta-carotene supplementation of pregnant women is superior to beta-carotene supplementation alone in improving vitamin A status in both mothers and infants 2004 · beta-carotene · Pregnant women; age and specific condition not stated | 4.5 mg | — | — |
| Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women 2009 · vitamin A and β-carotene (VA+BC) · HIV-infected pregnant women enrolled at 12–27 weeks of gestation in Dar es Salaam, Tanzania; women breastfeeding postpartum | 30 mg | — | — |
| Antioxidants, Helicobacter pylori and stomach cancer in Venezuela 1996 · Treatment 1 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified | 18 mg | 7 days | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · V (vitamins) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 6 mg | 26 weeks | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · vitamin group · Hospitalized adults older than 65 years; baseline vitamin C deficiency was common | 6 mg | 2 years | — |
| Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX 1997 · vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care | 6 mg | 1 year | — |
| Beta-carotene concentration in buccal mucosal cells with and without dysplastic oral leukoplakia after long-term beta-carotene supplementation in male smokers 1998 · beta-carotene plus alpha-tocopherol · Male smokers in the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study; age and health conditions not specified | 20 mg | — | — |
| Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial 2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception | 720 mcg | — | 870 |
| Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET) 2005 · Active intervention group (beta-carotene and/or retinol) · Adults in CARET Vanguard, including asbestos-exposed participants and smokers | 30 mg | 2557 days | 863 |
| Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial 2023 · control · Women planning pregnancy; generally healthy, recruited before conception | 720 mcg | — | 859 |
| Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled Study 2018 · VMP (Nutrilite Double X™) · Generally healthy adults aged 40–70 years in Moscow with low habitual recommended-food intake (recommended food score <12), predominantly women; no chronic diseases | 3 mg | 8 weeks | 60 |
| Effects of beta-carotene fortified synbiotic food on metabolic control of patients with type 2 diabetes mellitus: A double-blind randomized cross-over controlled clinical trial 2016 · beta-carotene fortified synbiotic food · Patients with type 2 diabetes mellitus | 150 mg | 6 weeks | 51 |
| [Effects of vitamins E, C and beta-carotene on DNA damage] 1999 · trial group · Healthy men aged 50–59 years | 25 mg | 20 weeks | 50 |
| Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial 2021 · Liposomal group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis | 4 mg | 90 days | 25 |
| Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial 2021 · Cyclodextrin group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis | 4 mg | 90 days | 25 |
| Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial 2021 · MCT group · Patients aged 16–55 years with pancreatic-insufficient cystic fibrosis | 4 mg | 90 days | 25 |
| Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid peroxidation in healthy young men on a low-carotenoid diet supplemented with tomato juice 2005 · tomato juice · healthy, non-smoking young men on a low-carotenoid diet | 1.6 mg | 2 weeks | 22 |
| Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid peroxidation in healthy young men on a low-carotenoid diet supplemented with tomato juice 2005 · carrot juice · healthy, non-smoking young men on a low-carotenoid diet | 27.1 mg | 2 weeks | 22 |
| Antioxidant vitamins and low-density-lipoprotein oxidation 1993 · antioxidant supplementation · Adults; ages and health conditions not stated | 18 mg | 26 weeks | 22 |
| Antioxidant therapy for recurrent pancreatitis: biochemical profiles in a placebo-controlled trial 1992 · active treatment · Patients with recurrent non-gallstone pancreatitis | 9,000 IU | 10 weeks | 20 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · softgel half-dose (single softgel) · Healthy adults aged 18–45 years, women and men | 8.6 mg | 1 day | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · softgel full-dose (two softgels) · Healthy adults aged 18–45 years, women and men | 17.2 mg | 1 day | 15 |
| Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study 2014 · tablet full-dose (four tablets) · Healthy adults aged 18–45 years, women and men | 17.2 mg | 1 day | 15 |
| Antioxidant supplementation enhances neutrophil oxidative burst in trained runners following prolonged exercise 2003 · antioxidant vitamin supplement · Healthy trained endurance runners; 6 men and 6 women, mean age 30.1 years | 18 mg | 7 days | 12 |
| Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation 1993 · combined antioxidant therapy · adult male subjects; age and health condition not specified | 30 mg | 90 days | 12 |
| Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients 2005 · antioxidant supplementation phase · renal transplant recipients taking cyclosporin A; age and sex not reported | 6 mg | 26 weeks | 10 |
| Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial 1999 · Antioxidant vitamins · Men aged 30–49 with plasma homocysteine concentration ≥8.34 μmol/L | 9 mg | 8 weeks | — |
| The effect of antenatal vitamin A and beta-carotene supplementation on gut integrity of infants of HIV-infected South African women 2001 · vitamin A group · HIV-infected pregnant South African women; age not stated | 30 mg | — | — |
| Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study 2001 · Antioxidant supplementation group · Women aged 35–60 years and men aged 45–60 years in France, general population | 6 mg | 2 years | — |
| Diet supplementation with vitamin E, vitamin C and beta-carotene cocktail enhances basal neutrophil antioxidant enzymes in athletes 2002 · antioxidant-supplemented group · Sportsmen; age and health condition not specified | 30 mg | 90 days | — |
| Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function 2003 · group B [high dose of supplement] · Patients with cystic fibrosis; age and sex not specified | 25 mg | 8 weeks | — |
| Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoids, xinc and selenium after micronutrient supplementation during alcohol rehabilitation 2003 · micronutrient supplement group · Alcohol-dependent patients aged 20 to 60 years without severe liver disease, hospitalized for alcohol rehabilitation | 6 mg | 3 weeks | — |
| Antioxidant diet supplementation influences blood iron status in endurance athletes 2004 · antioxidant supplemented · Amateur trained male endurance athletes | 30 mg | 90 days | — |
| Zinc plus beta-carotene supplementation of pregnant women is superior to beta-carotene supplementation alone in improving vitamin A status in both mothers and infants 2004 · beta-carotene plus zinc · Pregnant women; age and specific condition not stated | 4.5 mg | — | — |
| Response of blood cell antioxidant enzyme defences to antioxidant diet supplementation and to intense exercise 2006 · antioxidant supplemented · Amateur trained male athletes; age and health condition not specified | 30 mg | 90 days | — |
| Modification of lymphocyte DNA damage by carotenoid supplementation in postmenopausal women 2006 · mixed carotenoids · Healthy, nonsmoking postmenopausal women aged 50–70 years | 4 mg | 8 weeks | — |
| Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults 2006 · overweight adults receiving antioxidant treatment · overweight adults aged 18–30 years | 10 mg | 8 weeks | — |
| Antioxidant supplementation lowers exercise-induced oxidative stress in young overweight adults 2006 · normal-weight adults receiving antioxidant treatment · normal-weight adults aged 18–30 years | 10 mg | 8 weeks | — |
| Multivitamin-mineral supplementation prevents lipid peroxidation during "the Marathon des Sables" 2007 · Supplemented group · Athletes participating in the Marathon des Sables; age and sex not specified | 4.8 mg | 4 weeks | — |
| Antioxidant diet supplementation enhances aerobic performance in amateur sportsmen 2007 · antioxidant-supplemented group · Amateur male athletes; age and health condition not stated | 30 mg | 90 days | — |
| Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women 2009 · multivitamins including vitamin A and β-carotene · HIV-infected pregnant women enrolled at 12–27 weeks of gestation in Dar es Salaam, Tanzania; women breastfeeding postpartum | 30 mg | — | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 1 · Adults aged 60–75 years; elderly participants | 16.7 mg | 16 weeks | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 2 · Adults aged 60–75 years; elderly participants | 8.4 mg | 16 weeks | — |
| [Study the effect of antioxidant vitamin E, vitamin C and beta-carotene supplement on erythrocyte functions in elderly person] 2008 · Group 3 · Adults aged 60–75 years; elderly participants | 5.6 mg | 16 weeks | — |
| Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults 2009 · Normal-weight antioxidant-treated (N-AOX) · Apparently healthy men and women aged 18–30 years with BMI <25 kg/m² | 10 mg | 8 weeks | — |
| Effects of antioxidant supplementation on insulin sensitivity, endothelial adhesion molecules, and oxidative stress in normal-weight and overweight young adults 2009 · Overweight antioxidant-treated (O-AOX) · Apparently healthy men and women aged 18–30 years with BMI ≥25 kg/m² | 10 mg | 8 weeks | — |
| Multinutrient-fortified juices improve vitamin D and vitamin E status in children: a randomized controlled trial 2014 · CaDEA · Children aged approximately 8 years | 2,000 IU | 12 weeks | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS antioxidants only · Adults aged 55–80 with early or more advanced age-related macular degeneration | 15 mg | 5 years | — |
| The effect of long-term beta-carotene and vitamin A administration on serum concentrations of alpha-tocopherol 1994 · beta-carotene and vitamin A active agents · Participants enrolled in the Carotene and Retinol Efficacy Trial; age, sex, and health condition not specified | 30 mg | 6 years | — |
| Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise 1993 · antioxidant vitamin group · Young healthy males, mean age 25.0 years | 30 mg | 6 weeks | — |
| Antioxidants, Helicobacter pylori and stomach cancer in Venezuela 1996 · Treatment 2 · People with precancerous stomach lesions, including chronic gastritis, chronic atrophic gastritis, intestinal metaplasia or dysplasia; age and sex not specified | 15 mg | 7 days | — |
| Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network 1996 · VT (vitamins associated with trace elements) · Elderly nursing-home residents aged 65–103 years who were long-term hospitalized | 6 mg | 26 weeks | — |
| Enhanced plasma level of lipid peroxidation in Iranians could be improved by antioxidants supplementation 1997 · beta-carotene plus alpha-tocopherol · Male medical students; age not reported; no condition reported | 30 mg | 10 weeks | — |
| Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease 1997 · mid-dose · Patients with established cardiovascular disease | 12 mg | 12 weeks | — |
| Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease 1997 · high dose · Patients with established cardiovascular disease | 24 mg | 12 weeks | — |
| Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on levels of nutrients and antioxidant defense parameters 1997 · mineral and vitamin group · Hospitalized adults older than 65 years; baseline deficiencies of vitamin C, zinc and selenium were common | 6 mg | 2 years | — |
| Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX 1997 · trace elements associated with vitamins · Institutionalized elderly subjects in long-term hospital or nursing-home care | 6 mg | 1 year | — |
| Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects 1998 · supplementation group · Adult men aged 45–60 years and women aged 35–60 years | 6 mg | 26 weeks | — |
| Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers 1998 · antioxidants without n-3 fatty acids · adult male smokers with hyperlipidaemia | 15 mg | 6 weeks | — |
| Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3) 1996 · intervention group · Patients with suspected acute myocardial infarction; age and sex not stated | 25 mg | 4 weeks | 63 |
| Folate levels determine effect of antioxidant supplementation on micronuclei in subjects with cardiovascular risk 2004 · antioxidant-supplemented group · Middle-aged men: myocardial infarction survivors younger than 50 and healthy controls | 6 mg | 12 weeks | 53 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · Y2 · Healthy young adults aged 18–22 years | 1.5 mg | 60 days | 45 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · O2 · Healthy older adults aged 60–75 years | 1.5 mg | 60 days | 45 |
| [Metabolic estimation of efficiency of vitamin and mineral complexes in qualified athletes] 2021 · main group · Professional athletes in cyclic sports; age and sex not stated | 1.5 mg | 30 days | 42 |
| [Effect of multiple micronutrients supplementation on anti-oxidative activity and oxidized DNA damage of lymphocytes in children] 2005 · supplement group · Chinese children aged 9–11 years, described as healthy and living in a rural area | 1 mg | 8 weeks | 41 |
| Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people 2011 · C2 · Healthy children aged 8–10 years | 1 mg | 60 days | 40 |
| Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status 1991 · antioxidant-supplemented men · Men with low antioxidant status | 27 mg | 150 days | 39 |
| Dietary supplementation with a natural carotenoid mixture decreases oxidative stress 2003 · Fish oil plus natural carotenoid mixture · Healthy, free-living, nonsmoking adults | 6 mg | 3 weeks | 31 |
| Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial 1994 · supplemented group · Healthy men aged 30–58 years who smoked 15–40 cigarettes per day | 30 mg | 90 days | 20 |
| Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial 1999 · B vitamins with antioxidant vitamins · Men aged 30–49 with plasma homocysteine concentration ≥8.34 μmol/L | 9 mg | 8 weeks | — |
| Effect of antioxidant supplementation on urine and blood markers of oxidative stress during extended moderate-altitude training 1999 · antioxidant supplement (S) group · US Marine Corps volunteers undergoing 14 days of winter training at approximately 2700 m | 20,000 IU | 2 weeks | — |
| Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study 2005 · antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years | 6 mg | 2738 days | — |
| Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration 2007 · antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration | 15 mg | 2433 days | — |
| Antioxidant micronutrients and biomarkers of oxidative stress and inflammation in colorectal adenoma patients: results from a randomized, controlled clinical trial 2010 · antioxidant micronutrient combination · Patients with a history of sporadic colorectal adenoma; age and sex not specified | 24 mg | 120 days | — |
| Effects of 6 weeks of n-3 fatty acids and antioxidant mixture on lipid peroxidation at rest and postexercise 2011 · LCPUFA plus antioxidant mixture · Judoists; age and sex not reported; no diagnosed condition stated | 6 mg | 6 weeks | — |
| Antioxidant micronutrient supplementation increases erythrocyte membrane fluidity in adults from a rural Chinese community 2011 · A2 · Children; age range and sex not reported | 1 mg | 60 days | — |
| Antioxidant micronutrient supplementation increases erythrocyte membrane fluidity in adults from a rural Chinese community 2011 · B2 · Young people; age range and sex not reported | 1.5 mg | 60 days | — |
| Antioxidant micronutrient supplementation increases erythrocyte membrane fluidity in adults from a rural Chinese community 2011 · C2 · Elderly subjects; age range and sex not reported | 1.5 mg | 60 days | — |
| Tomato Phytonutrients Balance UV Response: Results from a Double-Blind, Randomized, Placebo-Controlled Study 2019 · active-supplement group · healthy volunteers; age and sex not specified | 800 mcg | 12 weeks | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS antioxidants plus zinc · Adults aged 55–80 with early or more advanced age-related macular degeneration | 15 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 15 mg | 5 years | — |
| Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration 2025 · AREDS2 original AREDS formulation with low zinc · Adults aged 50–85 with large drusen in both eyes or late AMD in one eye and large drusen in the fellow eye who accepted the additional AREDS formulation | 15 mg | 5 years | — |
| Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants 1997 · antioxidants · male smokers with combined hyperlipidemia | 15 mg | 6 weeks | — |
| Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants 1997 · omega-3 FAs and antioxidants · male smokers with combined hyperlipidemia | 15 mg | 6 weeks | — |
| Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers 1998 · n-3 fatty acids with antioxidants · adult male smokers with hyperlipidaemia | 15 mg | 6 weeks | — |
| Supplementation with antioxidants prior to bone marrow transplantation 1997 · Healthy control group · Healthy controls | 45 mg | 3 weeks | 10 |
| Redistribution of vitamin A after iron supplementation in Indonesian infants 2003 · 10 mg Zn + 2.4 mg beta-carotene · Indonesian infants aged 4 months | 2.4 mg | 26 weeks | — |
| Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration 2007 · antioxidants · Adults aged 55–80 with age-related macular degeneration | 15 mg | 2433 days | — |
| Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk 2009 · β-carotene group · Men aged 50–69 years in southwestern Finland who smoked at least five cigarettes per day | 20 mg | 2228 days | — |
| Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk 2009 · β-carotene plus vitamin E group · Men aged 50–69 years in southwestern Finland who smoked at least five cigarettes per day | 20 mg | 2228 days | — |